SGL
FENC icon

Sonic GP LLC’s Fennec Pharmaceuticals FENC Stock Holding History

Sonic GP LLC’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$15.2M Hold
2,407,357
– – 33.54% 1
2024
Q3 		$12M Hold
2,407,357
– – 27.51% 1
2024
Q2 		$14.7M Hold
2,407,357
– – 30.37% 1
2024
Q1 		$26.8M Hold
2,407,357
– – 35.34% 1
2023
Q4 		$27M Hold
2,407,357
– – 31.03% 1
2023
Q3 		$18.1M Hold
2,407,357
– – 17.55% 1
2023
Q2 		$21.3M Hold
2,407,357
– – 14.19% 1
2023
Q1 		$20M Hold
2,407,357
– – 15.3% 1
2022
Q4 		$23.1M Buy
+2,407,357
New +$21.3M 17.34% 1

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sonic GP LLC's FENC Position: Q4 2024 in Review

Sonic GP LLC held its Fennec Pharmaceuticals (FENC) position steady in Q4 2024 at 2,407,357 shares worth $15.2M. The position accounts for 33.54% of the portfolio, ranked #1.

Sonic GP LLC first reported a position in FENC in Q4 2022 and has held it in 9 quarters since. The position peaked at $27M in Q4 2023. 64 funds tracked by Wall St. Rank hold FENC as of Q4 2024.

  • Sonic GP LLC held 2,407,357 shares of Fennec Pharmaceuticals worth $15.2M as of Q4 2024.
  • Sonic GP LLC left its Fennec Pharmaceuticals share count unchanged in Q4 2024.
  • Fennec Pharmaceuticals made up 33.54% of Sonic GP LLC's portfolio in Q4 2024, its #1 holding.
  • Sonic GP LLC first reported a position in Fennec Pharmaceuticals in Q4 2022 and has held it in 9 quarters since.
  • Sonic GP LLC's Fennec Pharmaceuticals position peaked at $27M in Q4 2023.
  • 64 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q4 2024.

Based on Sonic GP LLC's 13F filing for Q4 2024, filed 14 Feb 2025.